Xebio Holdings Co., Ltd. (TYO:8281)
Japan · Delayed Price · Currency is JPY 1,133.00
-1.00 (-0.09%)
Sep 4, 2026, 3:30 PM JST
Xebio Holdings Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 256,265 | 252,331 | 250,603 | 242,433 | 239,293 | 223,282 | |
Revenue Growth | 2.60% | 0.69% | 3.37% | 1.31% | 7.17% | 10.30% |
Cost of Revenue | 159,870 | 157,237 | 152,931 | 149,546 | 147,519 | 136,228 |
Gross Profit | 96,395 | 95,094 | 97,672 | 92,887 | 91,774 | 87,054 |
Selling, General & Admin | 86,191 | 86,080 | 84,898 | 84,221 | 79,900 | 78,439 |
Operating Expenses | 92,834 | 92,723 | 90,665 | 88,682 | 83,446 | 82,054 |
Operating Income | 3,561 | 2,371 | 7,007 | 4,205 | 8,328 | 5,000 |
Interest Expense | -131 | -103 | -105 | -104 | -64 | -120 |
Interest & Investment Income | 65 | 60 | 39 | 98 | 87 | 59 |
Currency Exchange Gain (Loss) | 1,305 | 1,204 | 197 | 555 | 323 | 559 |
Other Non Operating Income (Expenses) | 1,132 | 1,128 | 480 | 650 | 566 | 2,353 |
EBT Excluding Unusual Items | 5,932 | 4,660 | 7,618 | 5,404 | 9,240 | 7,851 |
Gain (Loss) on Sale of Investments | -662 | -662 | -613 | 4 | - | -19 |
Gain (Loss) on Sale of Assets | -6 | -2,343 | -10 | 2 | 5 | -13 |
Asset Writedown | -3,868 | -3,861 | -3,840 | -724 | -777 | -1,583 |
Other Unusual Items | -317 | -111 | -78 | -166 | 366 | -22 |
Pretax Income | 1,079 | -2,317 | 3,077 | 4,520 | 8,834 | 6,214 |
Income Tax Expense | 963 | 106 | 2,098 | 1,789 | 3,241 | 2,361 |
Earnings From Continuing Operations | 116 | -2,423 | 979 | 2,731 | 5,593 | 3,853 |
Minority Interest in Earnings | 251 | 259 | -8 | -139 | -196 | -17 |
Net Income | 367 | -2,164 | 971 | 2,592 | 5,397 | 3,836 |
Net Income to Common | 367 | -2,164 | 971 | 2,592 | 5,397 | 3,836 |
Net Income Growth | - | - | -62.54% | -51.97% | 40.69% | 831.07% |
Shares Outstanding (Basic) | 41 | 41 | 43 | 44 | 44 | 44 |
Shares Outstanding (Diluted) | 41 | 41 | 43 | 44 | 44 | 44 |
Shares Change | 0.01% | -4.30% | -2.66% | 0.11% | 0.04% | 0.07% |
EPS (Basic) | 8.87 | -52.27 | 22.60 | 58.63 | 122.07 | 86.77 |
EPS (Diluted) | 8.87 | -52.27 | 22.46 | 58.31 | 121.58 | 86.44 |
EPS Growth | - | - | -61.48% | -52.04% | 40.65% | 830.46% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 2,324 | 5,349 | -51 | 3,663 | -1,286 |
Free Cash Flow Per Share | - | 56.13 | 123.64 | -1.15 | 82.51 | -28.98 |
Dividend Per Share | 35.000 | 35.000 | 32.500 | 30.000 | 30.000 | 30.000 |
Dividend Growth | 7.69% | 7.69% | 8.33% | 0% | 0% | 0% |
Gross Margin | 37.61% | 37.69% | 38.98% | 38.31% | 38.35% | 38.99% |
Operating Margin | 1.39% | 0.94% | 2.80% | 1.73% | 3.48% | 2.24% |
Profit Margin | 0.14% | -0.86% | 0.39% | 1.07% | 2.25% | 1.72% |
Free Cash Flow Margin | - | 0.92% | 2.13% | -0.02% | 1.53% | -0.58% |
EBITDA | 10,791 | 9,341 | 12,937 | 9,297 | 12,395 | 9,247 |
EBITDA Margin | 4.21% | 3.70% | 5.16% | 3.84% | 5.18% | 4.14% |
D&A For EBITDA | 7,230 | 6,970 | 5,930 | 5,092 | 4,067 | 4,247 |
EBIT | 3,561 | 2,371 | 7,007 | 4,205 | 8,328 | 5,000 |
EBIT Margin | 1.39% | 0.94% | 2.80% | 1.73% | 3.48% | 2.24% |
Effective Tax Rate | 89.25% | - | 68.18% | 39.58% | 36.69% | 38.00% |
Advertising Expenses | - | 6,423 | 6,882 | 7,401 | 6,372 | 6,194 |